Literature DB >> 1604698

Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras.

Y Zeng1, S T Ildstad, S M Wren, H L Rilo, D R Bereiter, P B Carroll, A G Tzakis, T E Starzl, C Ricordi.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1604698      PMCID： PMC2957115     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Insulin independence after islet transplantation into type I diabetic patient.

Authors:  D W Scharp; P E Lacy; J V Santiago; C S McCullough; L G Weide; L Falqui; P Marchetti; R L Gingerich; A S Jaffe; P E Cryer
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

2.  Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G L Warnock; N M Kneteman; E Ryan; R E Seelis; A Rabinovitch; R V Rajotte
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

4.  Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.

Authors:  D W Scharp; P E Lacy; J V Santiago; C S McCullough; L G Weide; P J Boyle; L Falqui; P Marchetti; C Ricordi; R L Gingerich
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

5.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

6.  Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow.

Authors:  W C Hartner; S R De Fazio; T Maki; T G Markees; A P Monaco; J J Gozzo
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

7.  Cross-species bone marrow transplantation: evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat----mouse).

Authors:  S T Ildstad; S M Wren; S S Boggs; M L Hronakes; F Vecchini; M R Van den Brink
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307
  7 in total
  3 in total

Review 1.  Alternatives to immunosuppressive drugs in human islet transplantation.

Authors:  Alison Anne Cotterell; Norma Sue Kenyon
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 2.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

3.  Comparison of the effect of bone marrow cells infusion through the portal vein and inferior vena cava combined with short-term rapamycin on allogeneic islet grafts in diabetic rats.

Authors:  Qingzhen Gao; Xiaoping Wang; Ruibin Zhang; Pu Wang; Yongsheng Jing; Wanjun Ren; Bin Zhu
Journal:  J Diabetes Investig       Date:  2016-01-23       Impact factor: 4.232
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.